Nucleotide binding by the widespread high-affinity cyclic di-GMP receptor MshEN domain

被引:0
|
作者
Yu-Chuan Wang
Ko-Hsin Chin
Zhi-Le Tu
Jin He
Christopher J. Jones
David Zamorano Sanchez
Fitnat H. Yildiz
Michael Y. Galperin
Shan-Ho Chou
机构
[1] Institute of Biochemistry,Department of Microbiology and Environmental Toxicology
[2] National Chung Hsing University,undefined
[3] Agricultural Biotechnology Center,undefined
[4] National Chung Hsing University,undefined
[5] State Key Laboratory of Agricultural Microbiology,undefined
[6] College of Life Science and Technology,undefined
[7] Huazhong Agricultural University,undefined
[8] University of California,undefined
[9] Santa Cruz,undefined
[10] National Center for Biotechnology Information,undefined
[11] National Library of Medicine,undefined
[12] National Institutes of Health,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
C-di-GMP is a bacterial second messenger regulating various cellular functions. Many bacteria contain c-di-GMP-metabolizing enzymes but lack known c-di-GMP receptors. Recently, two MshE-type ATPases associated with bacterial type II secretion system and type IV pilus formation were shown to specifically bind c-di-GMP. Here we report crystal structure of the MshE N-terminal domain (MshEN1-145) from Vibrio cholerae in complex with c-di-GMP at a 1.37 Å resolution. This structure reveals a unique c-di-GMP-binding mode, featuring a tandem array of two highly conserved binding motifs, each comprising a 24-residue sequence RLGxx(L/V/I)(L/V/I)xxG(L/V/I)(L/V/I)xxxxLxxxLxxQ that binds half of the c-di-GMP molecule, primarily through hydrophobic interactions. Mutating these highly conserved residues markedly reduces c-di-GMP binding and biofilm formation by V. cholerae. This c-di-GMP-binding motif is present in diverse bacterial proteins exhibiting binding affinities ranging from 0.5 μM to as low as 14 nM. The MshEN domain contains the longest nucleotide-binding motif reported to date.
引用
收藏
相关论文
共 50 条
  • [41] High-affinity, protective antibodies to the binding domain of botulinum neurotoxin type A
    Pless, DD
    Torres, ER
    Reinke, EK
    Bavari, S
    INFECTION AND IMMUNITY, 2001, 69 (01) : 570 - 574
  • [42] Peptides that mimic glycosaminoglycans: high-affinity ligands for a hyaluronan binding domain
    Ziebell, MR
    Zhao, ZG
    Luo, B
    Luo, Y
    Turley, EA
    Prestwich, GD
    CHEMISTRY & BIOLOGY, 2001, 8 (11): : 1081 - 1094
  • [43] Cyclic di-GMP modulates sessile-motile phenotypes and virulence in Dickeya oryzae via two PilZ domain receptors
    Chen, Yufan
    Lv, Mingfa
    Liang, Zhibin
    Liu, Zhiqing
    Zhou, Jianuan
    Zhang, Lian-Hui
    MOLECULAR PLANT PATHOLOGY, 2022, 23 (06) : 870 - 884
  • [44] Widespread expression in adult rat forebrain of mRNA encoding high-affinity neurotensin receptor
    Alexander, MJ
    Leeman, SE
    JOURNAL OF COMPARATIVE NEUROLOGY, 1998, 402 (04) : 475 - 500
  • [45] Structural basis of reversible high-affinity inhibition of connexin channels by cyclic nucleotide analogs
    Kapa, S
    Locke, D
    Harris, AL
    MOLECULAR BIOLOGY OF THE CELL, 2002, 13 : 221A - 221A
  • [46] Inactivation of Cyclic Di-GMP Binding Protein TDE0214 Affects the Motility, Biofilm Formation, and Virulence of Treponema denticola
    Bian, Jiang
    Liu, Xiangyang
    Cheng, Yi-Qiang
    Li, Chunhao
    JOURNAL OF BACTERIOLOGY, 2013, 195 (17) : 3897 - 3905
  • [47] HIGH-AFFINITY CYCLIC KGD-PEPTIDE BINDING TO GPIIB-IIIA
    SUEHIRO, K
    PLOW, EF
    CIRCULATION, 1994, 90 (04) : 346 - 346
  • [48] AZIDOMORPHINE IS AN AGONIST OF HIGH-AFFINITY OPIOID RECEPTOR-BINDING SITES
    HORVATH, K
    WOLLEMANN, M
    NEUROCHEMICAL RESEARCH, 1986, 11 (11) : 1565 - 1569
  • [49] ROLES OF GLOBOTRIOSYLSYLCERAMIDE AND GALABIOSYLCERAMIDE IN VEROTOXIN BINDING AND HIGH-AFFINITY INTERFERON RECEPTOR
    COHEN, A
    HANNIGAN, GE
    WILLIAMS, BRG
    LINGWOOD, CA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1987, 262 (35) : 17088 - 17091
  • [50] ANTIGEN-SPECIFIC INHIBITION OF IGE BINDING TO THE HIGH-AFFINITY RECEPTOR
    STAMPFLI, MR
    RUDOLF, M
    MIESCHER, S
    PACHLOPNIK, JM
    STADLER, BM
    JOURNAL OF IMMUNOLOGY, 1995, 155 (06): : 2948 - 2954